Mark Christopher Capone, Chief Operating Officer, MGL at MYRIAD GENETICS INC (MYGN), sold 36,000 shares at $43.15 ($1.6M) on 2009-04-06, disclosed to the SEC on 2009-04-07.
Scheduled sale ($1.6M) by Chief Operating Officer, MGL under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.02 | 22,500 | $968K | 62.4% |
| 2 | $43.15 | 13,500 | $583K | 37.6% |
| Total | $43.07 avg | 36,000 | $1.6M | 100% |
| Filing → |
| MYGN | SELL | 2018-07-13 | $3.3M | — | Filing → |
| MYGN | SELL | 2018-06-01 | $3.4M | — | Filing → |
| MYGN | BUY | 2016-08-19 | $425K | — | Filing → |